The Effect of the COVID-19 Epidemic Process on the Nutritional Habits and Body Weights of Adults

Sponsor
Istanbul Medeniyet University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05115084
Collaborator
(none)
160
5.9

Study Details

Study Description

Brief Summary

During the COVID-19 epidemic, the time spent by adults on the stomach has increased. Therefore, the likelihood of adverse changes in lifestyles has increased. In this study, the changes in nutritional habits, physical activities and body weights of adult individuals during the epidemic will be evaluated. A questionnaire including questions about nutritional habits, physical activity status and changes in body weights will be administered to individuals. The results will be evaluated with the appropriate statistical method. The survey will be administered once. The estimated time to reach the total number is 3 months.

Condition or Disease Intervention/Treatment Phase
  • Other: no intervention

Study Design

Study Type:
Observational
Anticipated Enrollment :
160 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
The Effect of the COVID-19 Epidemic Process on the Nutritional Habits and Body Weights of Adults
Anticipated Study Start Date :
Dec 3, 2021
Anticipated Primary Completion Date :
Jan 31, 2022
Anticipated Study Completion Date :
Jun 2, 2022

Outcome Measures

Primary Outcome Measures

  1. Questionnaire [12 weeks]

    A questionnaire containing a total of 45 questions will be applied, of which 10 are for demographic information, 31 for determining changes in body weight and eating habits, and 4 for physical activity.

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes

Inclusion Criteria: Adult individuals wishing to participate in the study -

Exclusion Criteria: Individuals outside the age range of 19-70 years, all individuals who did not agree to participate in the study.

-

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Istanbul Medeniyet University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gülin Öztürk Özkan, Associate professor, Istanbul Medeniyet University
ClinicalTrials.gov Identifier:
NCT05115084
Other Study ID Numbers:
  • 2021/23
First Posted:
Nov 10, 2021
Last Update Posted:
Nov 10, 2021
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 10, 2021